Pacific Edge reports second-quarter progress for Pacific Edge stock

Published on 10/19/2026 at 04:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Pacific Edge reported 2,867 US tests in the second quarter, down 13.00 percent from the first. Pacific Edge stock also logged 1,201 APAC tests.

US volume and reimbursement milestones

Pacific Edge reported 2,867 US commercial tests in the second quarter of fiscal 2027 on October 18, 2026.
Proposed 2027 Medicare rates are USD 1,026 for Cxbladder Monitor and USD 1,058 for Cxbladder Triage.
Pacific Edge stock was last quoted at NZD 0.24 on the NZX on October 19, 2026.
A five-year Veterans Administration agreement allocates USD 1.3 million for testing.

PEB, NZPEBE0002S1, Illustration mit AI erstellt.

Pacific Edge Limited reported 2,867 US commercial tests in the second quarter of fiscal 2027, down 13.00 percent from the first quarter. The update dated October 18, 2026 also showed APAC commercial volumes rising 3.70 percent to 1,201 tests, according to Quartr.

Reimbursement could reshape test economics

The proposed 2027 Medicare fee schedule would set reimbursement at USD 1,026 for Cxbladder Monitor and USD 1,058 for Cxbladder Triage, versus USD 760 for each product currently. That implies increases of 35.00 percent and 39.21 percent, respectively, subject to finalization.

Pacific Edge also secured a five-year Veterans Administration blanket purchase agreement allocating USD 1.3 million for Cxbladder Triage Plus and Monitor testing. In addition, Blue Cross plans in North and South Carolina agreed to in-network reimbursement from November 1, 2026, covering 8 million members, according to Quartr.

Three dates show the capital and volume path

On September 30, 2026, Pacific Edge recorded the lapse of 79,033 unquoted options. On September 30, 2026, option conversions added 12,214 ordinary shares, as reported by The Globe and Mail. On October 18, 2026, the trading update put US commercial volume at 2,867 tests and total laboratory throughput at 5,258 tests, according to Quartr.

What dates matter for the recovery?

The Blue Cross reimbursement agreements are scheduled to take effect on November 1, 2026. Proposed Medicare rates would apply from January 1, 2027, if finalized, while final Medicare coverage remains a key milestone before the end of 2026, according to Quartr.

Pacific Edge stock stays tied to execution

For investors, the operating picture is mixed in measurable terms: US volume fell 13.00 percent sequentially, while APAC volume increased 3.70 percent and Triage Plus reached 5.60 percent of US tests in the second quarter. Pacific Edge was last quoted at NZD 0.24 on the NZX on October 19, 2026 at 3:24 p.m. NZDT.